Winter Weather Can Bring Dry, Cracked Heels. Expert Offers Help
SUNDAY, Feb. 13, 2022 (HealthDay News) — Dry, cracked heels are common in the winter, but there are several ways to prevent and treat the problem, a skin specialist says.”Cold, dry weather, walking barefoot, and long, hot showers are just some of the…
Learn MoreWomen Should Take These 3 Things to Heart
SATURDAY, Feb. 12, 2022 (HealthDay News) — February is American Heart Month — the perfect time to remind women of three things they need to know about heart disease.It’s the leading cause of death among U.S. women, accounting for one in three deaths,…
Learn MorePhysician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Feb. 7 to 11, 2022. This roundup includes the latest research news from journal studies and other trusted sour…
Learn MoreFDA Postpones Decision on Pfizer COVID-19 Vaccine for Under 5s
FRIDAY, Feb. 11, 2022 (HealthDay News) — The U.S. Food and Drug Administration announced Friday that it will postpone an advisory panel meeting that was slated for next week to weigh the Pfizer COVID-19 vaccine for use in young children.The FDA took …
Learn MoreFDA Approves New Antibody Drug to Fight Omicron Variant
FRIDAY, Feb. 11, 2022 (HealthDay News) — The U.S. Food and Drug Administration on Friday gave the nod for a new monoclonal antibody treatment that works against the omicron variant.The emergency use authorization for bebtelovimab is for the treatment…
Learn MoreMandatory COVID-19 Tests Lifted for Vaccinated Travelers to Britain
FRIDAY, Feb. 11, 2022 (HealthDay News) — Vaccinated travelers will no longer have to take COVID-19 tests when they enter Britain, officials announced Friday.British residents and visitors who have had at least two doses of an approved COVID-19 vaccin…
Learn MoreFDA Panel Rejects Lilly Cancer Drug Tested Only in China
FRIDAY, Feb. 11, 2022 (HealthDay News) — A new lung cancer drug that has only been tested in China was soundly rejected by an advisory panel to the U.S. Food and Drug Administration on Thursday.Known as sintilimab, the treatment is a type of immunoth…
Learn MoreU.S. Buys 600,000 Doses of New COVID-19 Treatment Still Awaiting FDA Approval
FRIDAY, Feb. 11, 2022 (HealthDay News) — The U.S. government has bought 600,000 doses of a new antibody drug called bebtelovimab that seems able to beat back the omicron variant, even though the medication has yet to be given the green light by the U…
Learn MoreFDA Approves New Antibody Drug to Fight Omicron Variant
FRIDAY, Feb. 11, 2022 (HealthDay News) — The U.S. Food and Drug Administration on Friday gave the nod for a new monoclonal antibody treatment that works against the Omicron variant.The emergency use authorization for bebtelovimab is for the treatment…
Learn MoreLos CDC publican unos cambios propuestos en las directrices sobre los analgésicos opioides
JUEVES, 10 de febrero de 2022 (HealthDay News) — Los cambios propuestos en las directrices federales voluntarias para recetar analgésicos opioides enfatizan que los médicos deben intentarlo primero con otros tratamientos para el dolor agudo y crónico…
Learn More